Alzheimer's Disease (AD): Clinical Trials

43 trials for Alzheimer's Disease (AD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 15 recruiting, 7 not yet recruiting, 1 active not recruiting. 20 Not applicable, 9 Phase 1, 3 Early Phase 1, 3 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable20Recruiting 10, Not yet recruiting 5, Completed 3, Active not recruiting 1, Unknown 1
Phase 19Completed 6, Not yet recruiting 2, Recruiting 1
Early Phase 13Completed 2, Recruiting 1
Phase 23Completed 2, Terminated 1
Phase 41Completed 1

Follow Alzheimer's Disease (AD): new trials by email Literature Review of Alzheimer's Disease (AD) trials Research Report on Alzheimer's Disease (AD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improv Music Therapy for Older Adults
Clinical Improvisation - Alzheimer's Disease (AD), Older Adults (65 Years and Older)
Not applicableNot yet recruitingUniversity of California, San Francisco402026-12-012026-02-23
Negotiation Training for Family Caregivers of People With Alzheimer's Disease
NegotiAge, PlanYourLifespan - Alzheimer's Disease (AD), Dementia
Not applicableNot yet recruitingNorthwestern University2002026-11-012026-10-05
CMN LIFU for Enhanced Glymphatic Clearance in Amyloid-Positive MCI
ATTN201 Focused Ultrasound to the CMN, ATTN201 Unfocused Ultrasound - Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI)
Not applicableRecruitingUniversity of California, San Francisco282026-10-012026-10-14
The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease
Urolithin A, Placebo Control - Alzheimer's Disease (AD), Early Alzheimer's Disease
Not applicableRecruitingUniversity Hospital, Akershus602026-09-262026-10-08
Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients
8M2D, Placebo - Alzheimer's Disease (AD)
Phase 1Not yet recruitingCenna Biosciences Inc.542026-09-152026-05-05
Investigating the Effectiveness of Personalized Optimal Gamma Auditory Frequency Stimulation Intervention on Cognitive Function Enhancement
Personalized optimal gamma auditory frequency stimulation, Non-optimal gamma auditory frequency stimulation - Gamma Oscillations, Healthy Adults
Not applicableNot yet recruitingChang Gung Memorial Hospital202026-08-012026-07-16
Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.
ptau217 - Alzheimer's Disease (AD)
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven2402026-05-262026-06-24
Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease
blood sampling - Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Not applicableRecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS482026-05-182026-09-03
Improvement of Sleep Disorders in Patients With Alzheimer's Disease After Sunlight Exposure Therapy.
sunlight therapy - Alzheimer's Disease (AD), Sleep Disorders, Circadian Rhythm
Not applicableActive not recruitingNational Taiwan University Hospital602026-05-132026-07-17
Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI
Plase-Locked Acoustic Stimulation during slow-wave sleep, Phase-locked acoustic stimulation-Sham condition - Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI) Amnestic
Not applicableNot yet recruitingInstitut de Recerca Biomèdica de Lleida-Fundació Dr. Pifarré (IRBLleida)1142026-04-012026-04-14
Adapting RDAD for DS
Remote Exercise Sessions, Caregiver Education Sessions - Down Syndrome (DS), Alzheimer's Disease (AD)
Not applicableRecruitingUniversity of Kansas Medical Center402026-03-312026-08-03
Prospective Single-Arm Safety Study of Cervical LVA in AD Patients
Supermicrosurgical Lymphaticovenular Anastomosis (LVA) - Alzheimer's Disease (AD)
Phase 1Not yet recruitingChang Gung Memorial Hospital352026-03-012026-03-09
Social-cognitive Functioning: Validation of a New Neuropsychological Test
REALSOCOG, BCS, Hetero-questionnaires - Alzheimer's Disease (AD), Lewy Body Dementia (LBD)
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris1202026-02-042026-03-13
Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies
Biological : blood sampling, nasopharyngeal swab, Procedure : Lumbar puncture - Dementia With Lewy Bodies (DLB), Alzheimer's Disease (AD)
Not applicableNot yet recruitingUniversity Hospital, Strasbourg, France2862026-01-012025-09-10
Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease
Chronos battery - Alzheimer's Disease (AD), Time Perception
RecruitingUniversity Hospital, Caen402025-12-302026-03-19
Biofluid Research on Age-Related or Inherited Neurodegeneration
Frontotemporal Degeneration (FTD), ALS (Amyotrophic Lateral Sclerosis)
RecruitingUniversity of Pennsylvania10002025-12-122026-09-01
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease
Plasma p-tau217 and neurofilament light chain results - Alzheimer Blood Biomarkers, Alzheimer's Disease (AD)
Not applicableRecruitingAlzheimercentrum Amsterdam5502025-09-172026-07-02
Evaluation of SCALE PET Software for Quantitative Brain PET Analysis in Alzheimer's Disease
Neurophet SCALE PET - Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI)
Not applicableCompletedNEUROPHET1902025-06-022026-02-18
COGSCREEN II: Early Detection of Cognitive Impairment
Early Detection - Alzheimer's Disease (AD)
Not applicableRecruitingRobert Perneczky4002025-06-012026-03-12
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
[ 18F]3F4AP, [18F]MK6240, [11C]PIB - Demyelinating Disorders, MCI
Phase 1RecruitingYale University1052025-05-052026-09-09

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Alzheimer Disease (43)  ·  Cognitive Dysfunction (12)  ·  Dementia (9)  ·  Plaque, Amyloid (6)  ·  Neurodegenerative Diseases (4)  ·  Amyotrophic Lateral Sclerosis (3)  ·  Cognition Disorders (3)  ·  Lewy Body Disease (3)  ·  Parkinson Disease (3)  ·  Pick Disease of the Brain (3)  ·  Supranuclear Palsy, Progressive (3)  ·  Frontotemporal Dementia (2)  ·  Aphasia, Primary Progressive (1)  ·  Caregiver Burden (1)  ·  Chronic Traumatic Encephalopathy (1)

Broader conditions

Brain Diseases (43)  ·  Central Nervous System Diseases (43)  ·  Mental Disorders (43)  ·  Nervous System Diseases (43)  ·  Neurocognitive Disorders (43)  ·  Tauopathies (42)  ·  Neurodegenerative Diseases (39)  ·  Dementia (34)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Cognition Disorders (9)  ·  Basal Ganglia Diseases (6)  ·  Pathological Conditions, Anatomical (6)  ·  Frontotemporal Lobar Degeneration (5)  ·  Movement Disorders (5)  ·  Parkinsonian Disorders (5)

Interventions

7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (3)  ·  florbetapir (3)  ·  4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1)  ·  3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one (1)  ·  Blood Specimen Collection (1)  ·  Donepezil (1)  ·  Exercise Test (1)  ·  Functional Status (1)  ·  Lorazepam (1)  ·  Memantine (1)  ·  Neuropsychological Tests (1)  ·  Oxaloacetic Acid (1)  ·  Sodium Chloride (1)

Sponsors

Molecular NeuroImaging (3)  ·  University of Southern California (3)  ·  AbbVie (2)  ·  Chang Gung Memorial Hospital (2)  ·  Universitaire Ziekenhuizen KU Leuven (2)  ·  University of California, San Francisco (2)  ·  AC Immune SA (1)  ·  Alzheimercentrum Amsterdam (1)  ·  Amoneta Diagnostics SAS (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Atridia Pty Ltd. (1)  ·  Cenna Biosciences Inc. (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  HealthPartners Institute (1)

Countries

United States (18)  ·  France (5)  ·  Germany (3)  ·  Taiwan (3)  ·  Australia (2)  ·  Belgium (2)  ·  Canada (2)  ·  Netherlands (2)  ·  South Korea (2)  ·  Spain (2)  ·  China (1)  ·  Czechia (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)

Top investigators

Danna Jennings, MD (3)  ·  Michael W. Weiner, MD (2)  ·  Paul Aisen, MD (2)  ·  Amy Bodde, PhD (1)  ·  Andrew Krystal, MD (1)  ·  Corey McMillan, PhD (1)  ·  Cynthia Stonnington, MD (1)  ·  Donald R. Royall, MD (1)  ·  Elsmarieke van de Giessen, MD (1)  ·  Eric Guedj, Prof. (1)  ·  Evandro Fei Fang-Stavem, PhD (1)

Results publications

PMID 34187867, PMID 38853879, PMID 39219209, PMID 39324520, PMID 42862762, PMID 27908967, PMID 29107051, PMID 33719017, PMID 33773598, PMID 42348024, PMID 42565245

NIH funding

U01AG024904 (2), 2015 (1), 2017 (1), 2023 (1), K01AG088475 (1), KL2TR002367 (1), P01AG066597 (1), P30AG072979 (1), P41EB022544 (1), R01AG054029 (1), R01AG076153 (1), R01AG080548 (1), R01AG085561 (1), R01EB033582 (1), R56AG068421 (1)